Filter

Refine by date

—

Refine by collections

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 411 items for :

  • thyroid cancer x
Clear All
Markus Eszlinger Departments of Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada
Institute of Pathology, University Hospital Halle (Saale), Halle (Saale), Germany

Search for other papers by Markus Eszlinger in
Google Scholar
PubMed Close
,
Paul Stewardson Department of Medical Science and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada

Search for other papers by Paul Stewardson in
Google Scholar
PubMed Close
,
John B McIntyre Precision Oncology Hub Laboratory, Alberta Health Services, Tom Baker Cancer Centre, Calgary, Alberta, Canada

Search for other papers by John B McIntyre in
Google Scholar
PubMed Close
,
Adrian Box Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada

Search for other papers by Adrian Box in
Google Scholar
PubMed Close
,
Moosa Khalil Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada

Search for other papers by Moosa Khalil in
Google Scholar
PubMed Close
,
Martin Hyrcza Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada

Search for other papers by Martin Hyrcza in
Google Scholar
PubMed Close
,
Konstantin Koro Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada

Search for other papers by Konstantin Koro in
Google Scholar
PubMed Close
,
Dean Ruether Section of Medical Oncology, Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Canada

Search for other papers by Dean Ruether in
Google Scholar
PubMed Close
,
Jiahui Wu Department of Medical Science and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada

Search for other papers by Jiahui Wu in
Google Scholar
PubMed Close
, and
Ralf Paschke Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada

Search for other papers by Ralf Paschke in
Google Scholar
PubMed Close

mutation-positive medullary thyroid cancer (MTC) or RET gene fusion-positive thyroid cancer. The early approval of these drugs was based on phase 1/2 data ( 1 , 2 , 3 , 4 , 5 ). Patients with thyroid cancer were one of the larger patient groups in the

Article Type:
Research Article
Collections:
Thyroid cancer - basic and translational
DOI:
https://doi.org/10.1530/ETJ-21-0061
Volume/Issue:
Volume 11: Issue 1
Open access
Markus Eszlinger Department of Oncology and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada, and Institute of Pathology, University Hospital Halle, Halle, Germany

Search for other papers by Markus Eszlinger in
Google Scholar
PubMed Close
,
Alexandra Stephenson Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada

Search for other papers by Alexandra Stephenson in
Google Scholar
PubMed Close
,
Shideh Mirhadi Program in Cell Biology, Hospital for Sick Children, and Department of Molecular Genetics, University of Toronto, Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada

Search for other papers by Shideh Mirhadi in
Google Scholar
PubMed Close
,
Konrad Patyra Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland

Search for other papers by Konrad Patyra in
Google Scholar
PubMed Close
,
Michael F Moran Program in Cell Biology, Hospital for Sick Children, and Department of Molecular Genetics, University of Toronto, Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada

Search for other papers by Michael F Moran in
Google Scholar
PubMed Close
,
Moosa Khalil Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Moosa Khalil in
Google Scholar
PubMed Close
,
Jukka Kero Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland
Department of Pediatrics, Turku University Hospital, Turku, Finland

Search for other papers by Jukka Kero in
Google Scholar
PubMed Close
, and
Ralf Paschke Department of Oncology and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada, and Institute of Pathology, University Hospital Halle, Halle, Germany
Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada
Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Department of Medicine, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada

Search for other papers by Ralf Paschke in
Google Scholar
PubMed Close

/hormone synthesis ( 4 , 5 , 6 , 7 , 8 , 9 ). At variance with most other thyroid nodules, current textbooks and guidelines assess HTN as a low cancer risk with no further malignancy evaluation recommended ( 10 ). To understand the role of TSHR signaling in

Article Type:
Research Article
Collections:
Thyroid cancer - basic and translational
DOI:
https://doi.org/10.1530/ETJ-23-0049
Volume/Issue:
Volume 12: Issue 6
Open access
Jihwan Yoo Department of Neurosurgery, Brain Tumor Center, Gangnam Severance Hospital, Seoul, Republic of Korea
College of Medicine, Yonsei University, Seoul, Republic of Korea

Search for other papers by Jihwan Yoo in
Google Scholar
PubMed Close
,
Hee Jun Kim Department of Surgery, CHA Ilsan Medical Center, Cha University School of Medicine, Goyang-si, Republic of Korea

Search for other papers by Hee Jun Kim in
Google Scholar
PubMed Close
,
Seok Mo Kim Department of Surgery, Thyroid Cancer Center, Gangnam Severance Hospital, Institute of Refractory Thyroid Cancer, Yonsei University College of Medicine, Seoul, Republic of Korea

Search for other papers by Seok Mo Kim in
Google Scholar
PubMed Close
, and
Hun Ho Park Department of Neurosurgery, Brain Tumor Center, Gangnam Severance Hospital, Seoul, Republic of Korea

Search for other papers by Hun Ho Park in
Google Scholar
PubMed Close

Introduction Patients with differentiated thyroid cancer (DTC) generally have a good prognosis, even in cases of stage IV disease. The 10-year disease-specific survival rate is 82.6%, which is longer than that among patients with other

Article Type:
Research Article
Collections:
Thyroid cancer - clinical
DOI:
https://doi.org/10.1530/ETJ-22-0087
Volume/Issue:
Volume 11: Issue 5
Open access
Constance Xhaard U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Constance Xhaard in
Google Scholar
PubMed Close
,
Juan J. Lence-Anta National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Juan J. Lence-Anta in
Google Scholar
PubMed Close
,
Yan Ren U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Yan Ren in
Google Scholar
PubMed Close
,
Françoise Borson-Chazot Groupement Hospitalier Lyon-Est, Hospices Civils de Lyon, Fédération d'Endocrinologie, Bron
Rhône-Alpes Thyroid Cancer Registry, Cancer Research Center of Lyon (UMR INSERM 1052, CNRS 5286), RTH Laennec Faculty of Medicine, University of Lyon, Lyon

Search for other papers by Françoise Borson-Chazot in
Google Scholar
PubMed Close
,
Geneviève Sassolas Rhône-Alpes Thyroid Cancer Registry, Cancer Research Center of Lyon (UMR INSERM 1052, CNRS 5286), RTH Laennec Faculty of Medicine, University of Lyon, Lyon

Search for other papers by Geneviève Sassolas in
Google Scholar
PubMed Close
,
Claire Schvartz Thyroid Cancer Registry of Champagne-Ardennes, Institut Jean Godinot, Reims

Search for other papers by Claire Schvartz in
Google Scholar
PubMed Close
,
Marc Colonna Cancer Registry of Isère, Meylan

Search for other papers by Marc Colonna in
Google Scholar
PubMed Close
,
Brigitte Lacour Institut Gustave Roussy, Villejuif, France
French National Registry of Childhood Solid Tumours, CHU, Nancy

Search for other papers by Brigitte Lacour in
Google Scholar
PubMed Close
,
Arlette Danzon Cancer Registry of Doubs, EA 3181, Université de Franche-Comté, Besançon

Search for other papers by Arlette Danzon in
Google Scholar
PubMed Close
,
Michel Velten Cancer Registry of Bas-Rhin, EA 3430, Faculty of Medicine, University of Strasbourg, Strasbourg

Search for other papers by Michel Velten in
Google Scholar
PubMed Close
,
Enora Clero U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Enora Clero in
Google Scholar
PubMed Close
,
Stéphane Maillard U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Stéphane Maillard in
Google Scholar
PubMed Close
,
Emilie Marrer Cancer Registry of Haut-Rhin, Mulhouse Hospital, Mulhouse

Search for other papers by Emilie Marrer in
Google Scholar
PubMed Close
,
Laurent Bailly Public Health Department, University Hospital Nice, Nice

Search for other papers by Laurent Bailly in
Google Scholar
PubMed Close
,
Eugènia Mariné Barjoan Public Health Department, University Hospital Nice, Nice

Search for other papers by Eugènia Mariné Barjoan in
Google Scholar
PubMed Close
,
Martin Schlumberger Institut Gustave Roussy, Villejuif, France

Search for other papers by Martin Schlumberger in
Google Scholar
PubMed Close
,
Jacques Orgiazzi Department of Endocrinology, Hospices Civils de Lyon, Lyon, France

Search for other papers by Jacques Orgiazzi in
Google Scholar
PubMed Close
,
Elisabeth Adjadj U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Elisabeth Adjadj in
Google Scholar
PubMed Close
,
Celia M. Pereda National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Celia M. Pereda in
Google Scholar
PubMed Close
,
Silvia Turcios National Institute of Endocrinology, Cuba

Search for other papers by Silvia Turcios in
Google Scholar
PubMed Close
,
Milagros Velasco National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Milagros Velasco in
Google Scholar
PubMed Close
,
Mae Chappe National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Mae Chappe in
Google Scholar
PubMed Close
,
Idalmis Infante National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Idalmis Infante in
Google Scholar
PubMed Close
,
Marlene Bustillo National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Marlene Bustillo in
Google Scholar
PubMed Close
,
Anabel García National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Anabel García in
Google Scholar
PubMed Close
,
Sirced Salazar National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Sirced Salazar in
Google Scholar
PubMed Close
,
Regla Rodriguez Cuban Public Health Ministry, Havana, Cuba

Search for other papers by Regla Rodriguez in
Google Scholar
PubMed Close
,
Mohamed Amine Benadjaoud U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Mohamed Amine Benadjaoud in
Google Scholar
PubMed Close
,
Rosa M. Ortiz National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Rosa M. Ortiz in
Google Scholar
PubMed Close
,
Carole Rubino U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Carole Rubino in
Google Scholar
PubMed Close
, and
Florent de Vathaire U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Florent de Vathaire in
Google Scholar
PubMed Close

Introduction Over the last few decades, the differentiated thyroid cancer (DTC) incidence has grown rapidly in many countries [ 1 ]. The study of DTC risk factors is therefore of great importance to understand this observed increase in

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000445887
Volume/Issue:
Volume 5: Issue 2
Free access
Valentina M. Drozd The International Fund “Help for patients with radiation-induced thyroid cancer ‘Arnica’”, Minsk, Belarus
Project Chernobyl, Brooklyn, New York, USA

Search for other papers by Valentina M. Drozd in
Google Scholar
PubMed Close
,
Igor Branovan Project Chernobyl, Brooklyn, New York, USA

Search for other papers by Igor Branovan in
Google Scholar
PubMed Close
,
Nikolay Shiglik Project Chernobyl, Brooklyn, New York, USA

Search for other papers by Nikolay Shiglik in
Google Scholar
PubMed Close
,
Johannes Biko Clinic and Polyclinic of Nuclear Medicine, University of Würzburg, Würzburg, Germany

Search for other papers by Johannes Biko in
Google Scholar
PubMed Close
, and
Christoph Reiners The International Fund “Help for patients with radiation-induced thyroid cancer ‘Arnica’”, Minsk, Belarus
Clinic and Polyclinic of Nuclear Medicine, University of Würzburg, Würzburg, Germany

Search for other papers by Christoph Reiners in
Google Scholar
PubMed Close

Introduction During the last 30 years, the incidence of differentiated thyroid cancer (DTC) has steadily increased worldwide, most markedly in France, Italy, the Republic of Korea, Australia, and the USA [ 1 - 8 ]. In the USA, DTC incidence is

Article Type:
Review Article
DOI:
https://doi.org/10.1159/000485971
Volume/Issue:
Volume 7: Issue 2
Open access
Ilaria Muller Thyroid Research Group, School of Medicine, Cardiff University, Cardiff, United Kingdom

Search for other papers by Ilaria Muller in
Google Scholar
PubMed Close
,
Lucy S. Kilburn Institute of Cancer Research – Clinical Trials & Statistics Unit (ICR-CTSU), London, United Kingdom

Search for other papers by Lucy S. Kilburn in
Google Scholar
PubMed Close
,
Peter N. Taylor Thyroid Research Group, School of Medicine, Cardiff University, Cardiff, United Kingdom

Search for other papers by Peter N. Taylor in
Google Scholar
PubMed Close
,
Peter J. Barrett-Lee Academic Breast Department, Velindre Cancer Centre, Cardiff, United Kingdom

Search for other papers by Peter J. Barrett-Lee in
Google Scholar
PubMed Close
,
Judith M. Bliss Institute of Cancer Research – Clinical Trials & Statistics Unit (ICR-CTSU), London, United Kingdom

Search for other papers by Judith M. Bliss in
Google Scholar
PubMed Close
,
Paul Ellis Guy’s Hospital and King’s College, London, United Kingdom

Search for other papers by Paul Ellis in
Google Scholar
PubMed Close
,
Marian E. Ludgate Thyroid Research Group, School of Medicine, Cardiff University, Cardiff, United Kingdom

Search for other papers by Marian E. Ludgate in
Google Scholar
PubMed Close
, and
Colin M. Dayan Thyroid Research Group, School of Medicine, Cardiff University, Cardiff, United Kingdom

Search for other papers by Colin M. Dayan in
Google Scholar
PubMed Close

Introduction An association between breast cancer (BC) and benign thyroid disorders has been debated for decades, reported in several [ 1 , 2 ] but not all [ 3 ] studies; the most recent meta-analyses and reviews reached contrasting

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000460246
Volume/Issue:
Volume 6: Issue 4
Free access
Dillwyn Williams Department of Public Health, University of Cambridge, Cambridge, UK

Search for other papers by Dillwyn Williams in
Google Scholar
PubMed Close

and the pattern of occurrence of cancers would be expected. The thyroid is particularly unusual both in its growth pattern and in the behaviour of its cancers. To explore the relationship between thyroid growth and thyroid cancer, evidence from several

Article Type:
Review Article
DOI:
https://doi.org/10.1159/000437263
Volume/Issue:
Volume 4: Issue 3
Free access
Camille Buffet Department of Thyroid Pathologies and Endocrine Tumors, AP-HP, Pitié-Salpêtrière Hospital, Groupe de Recherche Clinique n°16 Tumeurs Thyroïdiennes, Sorbonne Université, Paris, France
UMR9019, Genome Integrity and Cancers, CNRS, Villejuif, France

Search for other papers by Camille Buffet in
Google Scholar
PubMed Close
,
Sophie Leboulleux Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Institut, Villejuif, France

Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed Close
,
Françoise Kraeber-Bodéré Nuclear Medicine Department, Université de Nantes, CHU de Nantes, CNRS, Inserm, CRCINA, Nantes, France
CHU Nantes/ICO, Saint-Herblain, France

Search for other papers by Françoise Kraeber-Bodéré in
Google Scholar
PubMed Close
,
Caroline Bodet-Milin Nuclear Medicine Department, Université de Nantes, CHU de Nantes, CNRS, Inserm, CRCINA, Nantes, France
CHU Nantes/ICO, Saint-Herblain, France

Search for other papers by Caroline Bodet-Milin in
Google Scholar
PubMed Close
,
Laure Cabanes Department of Cardiology, APHP, Cochin Hospital, Paris, France
Université de Paris, Paris, France

Search for other papers by Laure Cabanes in
Google Scholar
PubMed Close
,
Anthony Dohan Radiology Department, Université de Paris, Paris, France
Department of Radiology, AP-HP, Hôpital Cochin, Paris, France

Search for other papers by Anthony Dohan in
Google Scholar
PubMed Close
,
Pascal Leprince Department of Thoracic and Cardiovascular Surgery, Sorbonne Université, AP-HP, Pitié-Salpêtrière Hospital, Paris, France

Search for other papers by Pascal Leprince in
Google Scholar
PubMed Close
,
Martin Schlumberger UMR9019, Genome Integrity and Cancers, CNRS, Villejuif, France
Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Institute, Villejuif, France

Search for other papers by Martin Schlumberger in
Google Scholar
PubMed Close
,
Olivier Huillard Université de Paris, Sorbonne Paris Cité, Paris, France
Department of Medical Oncology, AP-HP, Hôpital Cochin, Paris, France

Search for other papers by Olivier Huillard in
Google Scholar
PubMed Close
, and
Lionel Groussin INSERM Unité 1016, CNRS UMR 8104, Institut Cochin, Paris, France
Université de Paris, Paris, France
Department of Endocrinology, AP-HP, Hôpital Cochin, Paris, France

Search for other papers by Lionel Groussin in
Google Scholar
PubMed Close

Established Facts Cardiac metastases from thyroid cancers are uncommon with a poor prognosis. Novel Insights Our work highlights 2 major points: The diagnostic challenge represented by cardiac metastases: in both

Article Type:
Case Report
DOI:
https://doi.org/10.1159/000517716
Volume/Issue:
Volume 10: Issue 6
Open access
Toru Takano Rinku General Medical Center, Izumisano, Japan
Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Suita, Japan
Department of Laboratory Medicine, Osaka University Graduate School of Medicine, Suita, Japan

Search for other papers by Toru Takano in
Google Scholar
PubMed Close

Introduction Thyroid cancer in children is a rare disease found in only a few children in a million. Since the Great East Japan Earthquake and following the Fukushima Daiichi Nuclear Plant accident in 2011, many children in Fukushima, Japan

Article Type:
Review Article
DOI:
https://doi.org/10.1159/000503323
Volume/Issue:
Volume 9: Issue 3
Open access
Jaume Capdevila Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology (VHIO), IOB Quiron-Teknon, Barcelona, Spain

Search for other papers by Jaume Capdevila in
Google Scholar
PubMed Close
,
Desiree’ Deandreis Department of Medical Sciences, Nuclear Medicine Unit, University of Turin, AOU Città della Salute e della Scienza, Turin, Italy

Search for other papers by Desiree’ Deandreis in
Google Scholar
PubMed Close
,
Cosimo Durante Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy

Search for other papers by Cosimo Durante in
Google Scholar
PubMed Close
,
Sophie Leboulleux Service of Endocrinology, Diabetology, University Hospital Geneve, Geneve, Switzerland

Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed Close
,
Markus Luster Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany

Search for other papers by Markus Luster in
Google Scholar
PubMed Close
,
Romana Netea-Maier Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by Romana Netea-Maier in
Google Scholar
PubMed Close
,
Kate Newbold Royal Marsden Hospital, London, United Kingdom

Search for other papers by Kate Newbold in
Google Scholar
PubMed Close
,
Susanne Singer Institute of Medical Biostatistics Epidemiology and Informatics (IMBEI), University Medical Center of Johannes Gutenberg University, Mainz, Germany

Search for other papers by Susanne Singer in
Google Scholar
PubMed Close
,
Gerasimos P Sykiotis Service of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland

Search for other papers by Gerasimos P Sykiotis in
Google Scholar
PubMed Close
,
Beate Bartes Association “Vivre sans Thyroïde”, Léguevin, France

Search for other papers by Beate Bartes in
Google Scholar
PubMed Close
,
Kate Farnell Butterfly Thyroid Cancer Trust, Rowlands Gill, Tyne & Wear, UK

Search for other papers by Kate Farnell in
Google Scholar
PubMed Close
, and
Laura Deborah Locati Medical Oncology Unit, IRCCS ICS Maugeri, Pavia, Italy
Department of Internal Medicine and Therapeutics, University of Pavia, Italy

Search for other papers by Laura Deborah Locati in
Google Scholar
PubMed Close

Introduction The incidence of thyroid cancer (TC) has steadily increased by 20% from 1990 to 2013 and is now predicted to be the fourth leading type of cancer globally ( 1 ). The increase has been ascribed primarily to the ability to detect

Article Type:
Research Article
Collections:
Thyroid cancer - clinical
DOI:
https://doi.org/10.1530/ETJ-23-0068
Volume/Issue:
Volume 12: Issue 5
Open access